中国药物经济学Issue(z1)：10-11,2.
低分子肝素钠治疗慢性阻塞性肺疾病急性加重期患者的疗效观察
Effect of Low Molecular Weight Heparin Sodium in the Treatment of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
杨永山 1赵文阁 1田强 1徐亚东1
作者信息
- 1. 大庆市人民医院呼吸内科，黑龙江大庆 163000
- 折叠
摘要
Abstract
Objective To investigate the application of low molecular weight heparin sodium in patients with chronic obstructive pulmonary disease with acute exacerbation(AECOPD).Methods 66 patients with AECOPD were randomly divided into study group and control group.The two groups were treated with conventional therapy,the study group were treated with low molecular weight heparin sodium 5000U,12 d,H 1 times,and the arterial blood gas analysis and pulmonary function were measured in 10 patients.Results After treatment,the arterial blood gas and pulmonary function of the study group were significantly better than those of the control group,the dif erence was statistical y significant(P<0.05).Conclusion The clinical effect of low molecular weight heparin sodium for treatment of patients with AECOPD is very significant.关键词
低分子肝素钠/慢性阻塞性肺疾病/急性/加重期/疗效Key words
Low molecular weight heparin sodium/Chronic obstructive pulmonary disease/Acute/Aggravating period/Curative effect分类
医药卫生引用本文复制引用
杨永山,赵文阁,田强,徐亚东..低分子肝素钠治疗慢性阻塞性肺疾病急性加重期患者的疗效观察[J].中国药物经济学,2015,(z1):10-11,2.
